Should you buy Colgate-Palmolive stock now?
Yes, the technical signal for Colgate-Palmolive is currently Strong Buy. Colgate-Palmolive trades at $98.69 as of Nov 6, 2026. The technical analysis shows the following: MACD is positive (bullish trend) at 2.318 with rising momentum (signal: 1.865); RSI is at 66.1 (neutral zone); the stock is in a short-term uptrend (price above the 20-day average); the analyst price target of $101.70 points to 3.0% upside. The stock is in a broader uptrend (above SMA50/SMA200). This is a technical observation based on current data, not investment advice.
What is the price target for Colgate-Palmolive stock?
The average analyst price target for Colgate-Palmolive is $101.70. The current price is $98.69, which gives an upside of 3.0%. Based on this, the stock is considered fairly valued. The fair value range (±10% of the price target) is between $91.53 and $111.87.
Is Colgate-Palmolive a dividend stock?
Yes, Colgate-Palmolive is a dividend stock with a dividend yield of 2.20%. The payout ratio is 54.4%, which is considered moderate. The next dividend payment is scheduled for Nov 13, 2026.
What is the risk of Colgate-Palmolive stock?
Colgate-Palmolive is rated as a stock in the risk category Unknown. Detailed risk data is currently not available.
Is Colgate-Palmolive overvalued?
Colgate-Palmolive is considered fairly valued – the price is close to the analyst price target. Colgate-Palmolive has the following valuation ratios: a P/E ratio of 37.3 (highly valued), a P/S ratio of 3.7, a P/B ratio of 263.9. The stock trades close to the analyst price target and is considered fairly valued.
Is Colgate-Palmolive overbought?
No, Colgate-Palmolive is not overbought. RSI is at 66.1 (neutral zone). The technical indicators show: RSI is at 66.1 (upper neutral zone), which shows positive momentum but is not yet overbought. In addition, the price is 5.4% above the 20-day average (short-term uptrend). In addition, MACD is positive with rising momentum (bullish).
When is the next Colgate-Palmolive earnings report?
The date of the next earnings report for Colgate-Palmolive has not been published yet. Check the company's investor calendar for updates.
Is Colgate-Palmolive shorted?
Yes, Colgate-Palmolive is shorted with 2.5% of the free float sold short. This is a moderate level of short selling, within the normal range for most stocks. The figure comes from our data provider EODHD, is reported about twice a month, and we check it every trading day.
Are insiders buying Colgate-Palmolive stock?
No, insiders are not buying Colgate-Palmolive shares – they are net sellers. Over the last 3 months, insiders have made 0 purchases and 1 sales. On a net basis, 920,500 $ worth of shares were sold. Across the last 20 reported transactions, the split is 0 purchases and 20 sales, with a net 65,592,593 $ sold. Active sellers include Tsourapas Panagiotis, CAHILL JOHN T, Wallace Noel R. and others. Insider selling can have several explanations (e.g. planned 10b5-1 sales, portfolio diversification or taxes), but sustained selling by several insiders is worth watching closely.
Is Colgate-Palmolive a good stock?
Based on our total score, Colgate-Palmolive is rated as a good stock with a total score of 65 out of 100. The stock scores above average on value, quality and momentum. The score is made up of Value: 20/100, Quality: 88/100, Momentum: 87/100. In addition: a dividend of 2.20%. Whether now is the time to buy is a separate question: the technical signal is Strong Buy. Whether Colgate-Palmolive is a good investment depends on your time horizon, risk profile and portfolio. This is a data-driven observation, not investment advice.
What is the outlook for Colgate-Palmolive stock?
The outlook for Colgate-Palmolive based on current data: the average analyst price target is $101.70 (+3.0%); the stock is in an uptrend (above SMA50 and SMA200); the P/E ratio is 37.3 (high – the market expects growth). Keep in mind that stock prices are affected by many factors, including earnings reports, the economy and market sentiment. Past returns are no guarantee of future returns.
Why is Colgate-Palmolive stock rising?
Colgate-Palmolive is rising right now. The technical indicators show: the price is 5.4% above the 20-day average; MACD is positive with rising momentum (bullish signal); insiders have mostly been selling the stock recently. For the latest context, see our technical analysis and insider section above.
How high can Colgate-Palmolive go?
The average analyst price target for Colgate-Palmolive is $101.70, which corresponds to a potential gain of 3.0% from the current price of $98.69. The stock has traded between $74.18 and $99.69 over the last 52 weeks. The price is close to the 52-week high. Keep in mind that price targets are estimates, not guarantees. Actual price moves depend on earnings, market conditions and unexpected events.
How low can Colgate-Palmolive fall?
The stock has traded as low as $74.18 over the last 52 weeks — that is 24.8% below the current price of $98.69. The biggest decline (drawdown) in the same period was 25.6% from high to low. Remember: past price swings are no guarantee for the future — a stock can fall further than the last 52 weeks suggest, especially on profit warnings, sector crises or a market crash. Use stop-loss orders and spread your portfolio to limit losses in single stocks.
What does Colgate-Palmolive do?
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toot... The company belongs to the Consumer Defensive sector, more specifically the Household & Personal Products industry, is headquartered in United States, and is traded on the USA Stocks. See the key figures, earnings history and price development above to evaluate Colgate-Palmolive as an investment.
Did Colgate-Palmolive raise or lower its guidance?
Over the last 60 days we have not registered a guidance raise or cut from Colgate-Palmolive. The company can still adjust its guidance at quarterly reports or between reports — see the earnings history above.
Is Colgate-Palmolive making money or losing money?
Yes, Colgate-Palmolive is making money, not losing it. The company has a profit margin (the share of revenue left over as profit) of 9.7% — which is moderate. The operating margin (profit before interest and taxes) is 20.4%. At a P/E ratio of 37.3, you currently pay 37.3 dollars for every dollar of the company's annual earnings. A consistently profitable company is usually more resilient than growth stocks that are not yet making money.
Can Colgate-Palmolive go bankrupt?
The bankruptcy risk of Colgate-Palmolive is rated as low. Altman Z2 (a model for assessing financial distress) is 6.54 — that places the company in the healthy zone. The company has a healthy balance sheet with limited debt relative to earnings and assets. The Piotroski score (financial health 0-9, higher is better) is 9 — which is strong. Debt relative to equity is 2,850% (high). Remember: models like Altman Z2 are statistical — unexpected shocks (fraud, a sector collapse, lawsuits) can always happen. Spread your portfolio.
Does Colgate-Palmolive have a lot of debt?
Yes, Colgate-Palmolive has elevated debt relative to equity. The debt-to-equity ratio (D/E — interest-bearing debt to equity) is 2,850%. For the consumer defensive sector, anything above 200% counts as elevated — that raises the financial risk, especially if interest rates rise or earnings fall. Consumer staples deliver predictable earnings — which allows higher debt than in cyclical industries. Note: D/E levels are highly sector-specific — a bank at 300% debt is normal, a tech stock at 300% is extremely leveraged. Always compare with similar companies in the same sector. Can Colgate-Palmolive service its debt? Can service its debt without problems — the interest coverage ratio (how many times earnings can cover interest payments) is 17.4x, and net debt equals 1.2 years of earnings (EBITDA).